| Literature DB >> 18559949 |
Gültekin Tamgüney1,2, Kurt Giles1,2, David V Glidden3, Pierre Lessard2, Holger Wille1,2, Patrick Tremblay1,2, Darlene F Groth2, Fruma Yehiely2, Carsten Korth2, Richard C Moore2, Jörg Tatzelt1, Eric Rubinstein4, Claude Boucheix4, Xiaoping Yang5, Pamela Stanley5, Michael P Lisanti6, Raymond A Dwek7, Pauline M Rudd7, Jackob Moskovitz8, Charles J Epstein9, Tracey Dawson Cruz10, William A Kuziel10, Nobuyo Maeda10, Jan Sap11, Karen Hsiao Ashe12, George A Carlson13, Ina Tesseur14, Tony Wyss-Coray15,14, Lennart Mucke16,17,1, Karl H Weisgraber18,16, Robert W Mahley18,16, Fred E Cohen19,2, Stanley B Prusiner1,2.
Abstract
Prion diseases are caused by conversion of a normally folded, non-pathogenic isoform of the prion protein (PrP(C)) to a misfolded, pathogenic isoform (PrP(Sc)). Prion inoculation experiments in mice expressing homologous PrP(C) molecules on different genetic backgrounds displayed different incubation times, indicating that the conversion reaction may be influenced by other gene products. To identify genes that contribute to prion pathogenesis, we analysed incubation times of prions in mice in which the gene product was inactivated, knocked out or overexpressed. We tested 20 candidate genes, because their products either colocalize with PrP, are associated with Alzheimer's disease, are elevated during prion disease, or function in PrP-mediated signalling, PrP glycosylation, or protein maintenance. Whereas some of the candidates tested may have a role in the normal function of PrP(C), our data show that many genes previously implicated in prion replication have no discernible effect on the pathogenesis of prion disease. While most genes tested did not significantly affect survival times, ablation of the amyloid beta (A4) precursor protein (App) or interleukin-1 receptor, type I (Il1r1), and transgenic overexpression of human superoxide dismutase 1 (SOD1) prolonged incubation times by 13, 16 and 19 %, respectively.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18559949 PMCID: PMC2828448 DOI: 10.1099/vir.0.2008/001255-0
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891